98 related articles for article (PubMed ID: 23578691)
21. Post-anesthesia vomiting: impact of isoflurane and morphine on ferrets and musk shrews.
Horn CC; Meyers K; Pak D; Nagy A; Apfel CC; Williams BA
Physiol Behav; 2012 Jun; 106(4):562-8. PubMed ID: 22504494
[TBL] [Abstract][Full Text] [Related]
22. The piglet as a suitable animal model for studying the delayed phase of cisplatin-induced emesis.
Milano S; Blower P; Romain D; Grélot L
J Pharmacol Exp Ther; 1995 Aug; 274(2):951-61. PubMed ID: 7636759
[TBL] [Abstract][Full Text] [Related]
23. Emesis-related biochemical and histopathological changes induced by cisplatin in the ferret.
Endo T; Minami M; Monma Y; Saito H; Takeuchi M
J Toxicol Sci; 1990 Nov; 15(4):235-44. PubMed ID: 1707101
[TBL] [Abstract][Full Text] [Related]
24. Action of cyclooxygenase inhibitors and a leukotriene biosynthesis inhibitor on cisplatin-induced acute and delayed emesis in the ferret.
Sam TS; Ngan MP; Riendeau D; Robichaud A; Rudd JA
J Pharmacol Sci; 2007 Feb; 103(2):189-200. PubMed ID: 17310074
[TBL] [Abstract][Full Text] [Related]
25. Methodology and assessment in clinical anti-emetic research: a meta-analysis of outcome parameters.
Morrow GR
Br J Cancer Suppl; 1992 Dec; 19():S38-41. PubMed ID: 1467200
[TBL] [Abstract][Full Text] [Related]
26. A study evaluating the efficacy and tolerability of tropisetron in combination with dexamethasone in the prevention of delayed platinum-induced nausea and emesis.
Sorbe BG; Berglind AM; Andersson H; Boman K; Högberg T; Hallgren M; Schmidt M
Cancer; 1998 Sep; 83(5):1022-32. PubMed ID: 9731907
[TBL] [Abstract][Full Text] [Related]
27. Prevention of cisplatin-induced acute and delayed emesis by the selective neurokinin-1 antagonists, L-758,298 and MK-869.
Van Belle S; Lichinitser MR; Navari RM; Garin AM; Decramer ML; Riviere A; Thant M; Brestan E; Bui B; Eldridge K; De Smet M; Michiels N; Reinhardt RR; Carides AD; Evans JK; Gertz BJ
Cancer; 2002 Jun; 94(11):3032-41. PubMed ID: 12115394
[TBL] [Abstract][Full Text] [Related]
28. 5-Hydroxyindoleacetic acid and substance P profiles in patients receiving emetogenic chemotherapy.
Higa GM; Auber ML; Altaha R; Piktel D; Kurian S; Hobbs G; Landreth K
J Oncol Pharm Pract; 2006 Dec; 12(4):201-9. PubMed ID: 17156592
[TBL] [Abstract][Full Text] [Related]
29. Cisplatin-induced early and delayed emesis in the pigeon.
Tanihata S; Igarashi H; Suzuki M; Uchiyama T
Br J Pharmacol; 2000 May; 130(1):132-8. PubMed ID: 10781008
[TBL] [Abstract][Full Text] [Related]
30. A randomized, double-blind comparison of single-dose and divided multiple-dose dolasetron for cisplatin-induced emesis.
Harman GS; Omura GA; Ryan K; Hainsworth JD; Cramer MB; Hahne WF
Cancer Chemother Pharmacol; 1996; 38(4):323-8. PubMed ID: 8674154
[TBL] [Abstract][Full Text] [Related]
31. Efficacy of maropitant for treatment and prevention of emesis caused by intravenous infusion of cisplatin in dogs.
de la Puente-Redondo VA; Tilt N; Rowan TG; Clemence RG
Am J Vet Res; 2007 Jan; 68(1):48-56. PubMed ID: 17199418
[TBL] [Abstract][Full Text] [Related]
32. Reduction of cisplatin-induced emesis by a selective neurokinin-1-receptor antagonist. L-754,030 Antiemetic Trials Group.
Navari RM; Reinhardt RR; Gralla RJ; Kris MG; Hesketh PJ; Khojasteh A; Kindler H; Grote TH; Pendergrass K; Grunberg SM; Carides AD; Gertz BJ
N Engl J Med; 1999 Jan; 340(3):190-5. PubMed ID: 9917226
[TBL] [Abstract][Full Text] [Related]
33. [A randomized controlled trial of acute and delayed cisplatin-induced emesis with metoclopramide, dexamethasone and prochlorperazine].
Nino S; Umehara H; Inoue I; Tamura T; Sasaki Y; Sakurai M; Shinkai T; Eguchi K; Saijo N; Suemasu K
Gan To Kagaku Ryoho; 1987 Oct; 14(10):2881-4. PubMed ID: 3310905
[TBL] [Abstract][Full Text] [Related]
34. Efficacy & tolerability of ondansetron compared to metoclopramide in dose dependent cisplatin-induced delayed emesis.
Bhatia A; Tripathi KD; Sharma M
Indian J Med Res; 2004 Sep; 120(3):183-93. PubMed ID: 15489556
[TBL] [Abstract][Full Text] [Related]
35. Computerized detection and analysis of cancer chemotherapy-induced emesis in a small animal model, musk shrew.
Huang D; Meyers K; Henry S; De la Torre F; Horn CC
J Neurosci Methods; 2011 Apr; 197(2):249-58. PubMed ID: 21392533
[TBL] [Abstract][Full Text] [Related]
36. [The control of chemotherapy-induced nausea and vomiting].
Shinkai T; Saijo N; Sawamura N; Funaki U; Takahashi S; Yokoyama S; Fujita J; Futami H; Sasaki Y; Shimizu E
Gan No Rinsho; 1985 Jun; 31(7):779-91. PubMed ID: 3897622
[TBL] [Abstract][Full Text] [Related]
37. A re-evaluation of the neurotransmitter basis of chemotherapy-induced immediate and delayed vomiting: evidence from the least shrew.
Darmani NA; Crim JL; Janoyan JJ; Abad J; Ramirez J
Brain Res; 2009 Jan; 1248():40-58. PubMed ID: 19022231
[TBL] [Abstract][Full Text] [Related]
38. The tachykinin NK1 receptor antagonist CP-99,994 attenuates cisplatin induced emesis in the ferret.
Tattersall FD; Rycroft W; Hargreaves RJ; Hill RG
Eur J Pharmacol; 1993 Nov; 250(1):R5-6. PubMed ID: 8119305
[TBL] [Abstract][Full Text] [Related]
39. Serotonin-independent model of cisplatin-induced emesis in the ferret.
Rudd JA; Cheng CH; Naylor RJ
Jpn J Pharmacol; 1998 Nov; 78(3):253-60. PubMed ID: 9869258
[TBL] [Abstract][Full Text] [Related]
40. Gastric myoelectric activity during cisplatin-induced acute and delayed emesis reveals a temporal impairment of slow waves in ferrets: effects not reversed by the GLP-1 receptor antagonist, exendin (9-39).
Lu Z; Ngan MP; Lin G; Yew DTW; Fan X; Andrews PLR; Rudd JA
Oncotarget; 2017 Nov; 8(58):98691-98707. PubMed ID: 29228720
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
